NCT06925737 2026-03-13
MK-2400-001
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
9 trialsNCT07100990 2026-03-11
TIMELY-PLEX
Mayo Clinic
Phase 3 Recruiting
NCT06888817 2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3 Recruiting
NCT06342544 2026-01-21
IMCOMG
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3 Recruiting
NCT06471465 2025-08-17
BRADI
Institut Cancerologie de l'Ouest
Phase 3 Recruiting
NCT00421174 2021-11-01
BMTCTN0403
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT02249377 2020-03-18
PRP vs Corticosteroid in Baker's Cyst
NYU Langone Health
Phase 3 Terminated
NCT02046603 2018-12-07
ACT-MOVE
Hoffmann-La Roche
Phase 3 Completed
NCT00661102 2016-11-02
A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).
Hoffmann-La Roche
Phase 3 Completed